WHO recommendations need manufacturers to apply a steady hazard management system for sterility test isolators, together with regular threat assessments and the development of danger-dependent control techniques. Manufacturers wanting to put into practice these approaches have to offer strong validation details to display their equivalence to pharmacopoeial approaches. As waiting for link from Forum Profiles (6)